Balancing histone methylation activities in psychiatric disorders

Trends in Molecular Medicine

Volumn 17, Issue 7, 2011, Pages 372-379

  Peter, Cyril Jayakumar ^a   Akbarian, Schahram ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIX 01294; CLOZAPINE; COCAINE; HISTONE LYSINE METHYLTRANSFERASE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VALPROIC ACID;

CHROMATIN STRUCTURE; COCAINE DEPENDENCE; COGNITION; CONVULSION; DEPRESSION; EMOTION; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; HISTONE LYSINE METHYLATION; HISTONE METHYLATION; HUMAN; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NONHUMAN; REVIEW; SCHIZOPHRENIA; TRANSCRIPTION REGULATION;

ANIMALS; EPIGENOMICS; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; METHYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PSYCHOTIC DISORDERS;

ANIMALIA;

EID: 79960276209     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.02.003     Document Type: Review

References (92)

1. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2010, 167:1305-1320.
2. Balu D.T., Coyle J.T. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci. Biobehav. Rev. 2011, 35:848-870.
3. Lewis D.A., Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 2006, 12:1016-1022.
4. Clay H.B., et al. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2010, (Epub ahead of print).
5. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 2010, 15:326-336.
6. Tsankova N., et al. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8:355-367.
7. Akbarian S., Huang H.S. Epigenetic regulation in human brain-focus on histone lysine methylation. Biol. Psychiatry 2009, 65:198-203.
8. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
9. Marks P.A. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin. Investig. Drugs 2010, 19:1049-1066.
10. Covington H.E., et al. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 2009, 29:11451-11460.
11. Schroeder F.A., et al. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 2007, 62:55-64.
12. Tsankova N.M., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9:519-525.
13. Zhu H., et al. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors. Behav. Brain Res. 2009, 196:200-206.
14. Dong E., et al. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12578-12583.
15. Renthal W., et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009, 62:335-348.
16. Fischer A., et al. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci. 2010, 31:605-617.
17. Zhou V.W., et al. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12:7-18.
18. Mosammaparast N., Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 2010, 79:155-179.
19. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 2002, 12:198-209.
20. Hu J.L., et al. The N-terminus of histone H3 is required for de novo DNA methylation in chromatin. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:22187-22192.
21. Ooi S.K., et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
22. Kondo Y., et al. Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7398-7403.
23. Karlic R., et al. Histone modification levels are predictive for gene expression. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2926-2931.
24. Kim T.K., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
25. Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 2008, 20:341-348.
26. Stadler F., et al. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J. Neurochem. 2005, 94:324-336.
27. Ernst C., et al. Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol. Psychiatry 2009, 14:830-832.
28. Huang H.S., et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci. 2007, 27:11254-11262.
29. Jiang Y., et al. Isolation of neuronal chromatin from brain tissue. BMC Neurosci. 2008, 9:42.
30. Cheung I., et al. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8824-8829.
31. Copeland R.A., et al. Protein methyltransferases as a target class for drug discovery. Nat. Rev. Drug Discov. 2009, 8:724-732.
32. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 2006, 75:243-269.
33. Fang R., et al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol. Cell 2010, 39:222-233.
34. Selvi B.R., et al. Small molecule modulators of histone acetylation and methylation: a disease perspective. Biochim. Biophys. Acta 2010, 10-12:810-828.
35. Kim S.Y., et al. Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J. Biol. Chem. 2007, 282:9962-9972.
36. Gupta S., et al. Histone methylation regulates memory formation. J. Neurosci. 2010, 30:3589-3599.
37. Lim D.A., et al. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 2009, 458:529-533.
38. Anderson S., et al. Differential origins of neocortical projection and local circuit neurons: role of Dlx genes in neocortical interneuronogenesis. Cereb. Cortex 1999, 9:646-654.
39. Zhang T.Y., et al. Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. J. Neurosci. 2010, 30:13130-13137.
40. Tahiliani M., et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007, 447:601-605.
41. Adegbola A., et al. A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am. J. Med. Genet. A 2008, 146A:505-511.
42. Ibrahim H.M., Tamminga C.A. Schizophrenia: treatment targets beyond monoamine systems. Annu. Rev. Pharmacol. Toxicol. 2010, 51:189-209.
43. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2007, 2:e809.
44. Yadav P.N., et al. The presynaptic component of the serotonergic system is required for clozapine's efficacy. Neuropsychopharmacology 2011, 36:638-651.
45. Kleefstra T., et al. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am. J. Hum. Genet. 2006, 79:370-377.
46. Fritsch L., et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell 2010, 37:46-56.
47. Schaefer A., et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 2009, 64:678-691.
48. Maze I., et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327:213-216.
49. Jiang Y., et al. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J. Neurosci. 2010, 30:7152-7167.
50. Sanacora G., et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 2008, 7:426-437.
51. Ayyanathan K., et al. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev. 2003, 17:1855-1869.
52. Jakobsson J., et al. KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron 2008, 60:818-831.
53. Wilkinson M.B., et al. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 2009, 29:7820-7832.
54. Herz H.M., Shilatifard A. The JARID2-PRC2 duality. Genes Dev. 2010, 24:857-861.
55. Pereira J.D., et al. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15957-15962.
56. Burgold T., et al. The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS ONE 2008, 3:e3034.
57. Kuzumaki N., et al. Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment. Hippocampus 2011, 127-132. doi:10.1002 (Epub ahead of print).
58. Hunter R.G., et al. Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20912-20917.
59. Li G., et al. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 2010, 24:368-380.
60. Pasini D., et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010, 464:306-310.
61. Pedrosa E., et al. Positive association of schizophrenia to JARID2 gene. Am. J. Med. Genet. B: Neuropsychiatry Genet. 2007, 144B:45-51.
62. Liu Y., et al. Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. J. Biomed. Biotechnol. 2009, 2009:536918.
63. Shen X., et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
64. Peng J.C., et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009, 139:1290-1302.
65. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
66. Berdasco M., et al. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21830-21835.
67. Edmunds J.W., et al. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 2008, 27:406-420.
68. Faber P.W., et al. Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet. 1998, 7:1463-1474.
69. Kirkwood S.C., et al. Progression of symptoms in the early and middle stages of Huntington disease. Arch. Neurol. 2001, 58:273-278.
70. Seong I.S., et al. Huntingtin facilitates polycomb repressive complex 2. Hum. Mol. Genet. 2010, 19:573-583.
71. Kim M.O., et al. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J. Neurosci. 2008, 28:3947-3957.
72. Ryu H., et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19176-19181.
73. Kelly T.K., et al. Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 2010, 28:1069-1078.
74. Huang J., Berger S.L. The emerging field of dynamic lysine methylation of non-histone proteins. Curr. Opin. Genet. Dev. 2008, 18:152-158.
75. Lall S. Primers on chromatin. Nat. Struct. Mol. Biol. 2007, 14:1110-1115.
76. Nicodeme E., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
77. Tan J., et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007, 21:1050-1063.
78. Akbarian S., et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 2005, 62:829-840.
79. Culhane J.C., et al. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J. Am. Chem. Soc. 2010, 132:3164-3176.
80. Black Y.D., et al. Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J. Neurosci. 2006, 26:9656-9665.
81. Porteous D.J., et al. The genetics and biology of DISC1 - an emerging role in psychosis and cognition. Biol. Psychiatry 2006, 60:123-131.
82. Green T., et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J. Am. Acad. Child Adolesc. Psychiatry 2009, 48:1060-1068.
83. Kane J.M., Correll C.U. Pharmacologic treatment of schizophrenia. Dialogues Clin. Neurosci. 2010, 12:345-357.
84. Papakostas G.I. The efficacy, tolerability, and safety of contemporary antidepressants. J. Clin. Psychiatry 2010, 71(Suppl. E1):e03.
85. Bonasio R., et al. Molecular signals of epigenetic states. Science 2010, 330:612-616.
86. Taverna S.D., et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 2007, 14:1025-1040.
87. Weake V.M., Workman J.L. Histone ubiquitination: triggering gene activity. Mol. Cell 2008, 29:653-663.
88. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13225-13230.
89. Justin N., et al. Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies. Curr. Opin. Struct. Biol. 2010, 20:730-738.
90. Vermeulen M., et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142:967-980.
91. Taverna S.D., et al. Long-distance combinatorial linkage between methylation and acetylation on histone H3N termini. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2086-2091.
92. Ku M., et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 2008, 4:e1000242.